Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Follow us on LinkedIn - https://www.linkedin.com/company/fatty-liver-alliance/
Signed in as:
filler@godaddy.com
With an estimated 30-40% of the world having MASLD (previously NAFLD) and trending towards even higher rates of advanced liver disease (MASH), do we have the infrastructure of people to support what is already here and what is yet to come?
Professor Jeffrey V. Lazarus joins Michael Betel and discusses his new paper, co-authored by Christopher Kopka, Alina Allen, and Zobair Younossi, "Is it time to expand the fatty liver disease community of practice".
Jeff Lazarus is the head of the Health Systems Research Group at Barcelona Institute for Global Health (ISGlobal) and Associate Professor at the University of Barcelona as well as a full professor at the CUNY Graduate School of Public Health and Health Policy, in New York.
He is a member of the Global NASH Council and the EASL | The Home of Hepatology, Public Health and Policy Committee, where he leads the global Healthy Livers, Healthy Lives coalition. He is the author of more than 300 publications, and his full CV is both lengthy and very impressive.
#masld #MASH #transplant #liver #cuny #jobalert
How will Primary Care Physicians and Endocrinologists incorporate and apply the The American Association for the Study of Liver Diseases (AASLD) NAFLD Guidance Statements that were recently released? Drs. Kenny Cusi and Hsiao-Ming Jung share an incredible amount of guidance and insights from their real world clinical experiences in this 4 part series.In the real world how compliant are NAFLD and NASH patients? Find out more about this important question with Dr. Ken Cusi and Dr. Hsiao-Ming Jung.
Camilla Dalby Hansen could possibly change the way you decide which foods to eat. What is the best and healthiest style of diet? Many of us grew up with low fat, but was that the best? Decades ago, it was low carb, high fat that was the rage. Keto, Mediterranean, what is the science and how will your choices impact your health and the health of your liver? Here are the results of a paper just out, and discussed at the last EASL | The Home of Hepatology conference.
With appreciation to, OUH Odense Universitetshospital – Svendborg Sygehus.
Dr. Giada Sebastiani, Hepatologist, is definitely one of the most passionate liver specialists we know! In this chat, she shares a research study she and her colleagues from the Canadian NASH Network(CanNASH) had published: "Canadian Survey on Knowledge of NAFLD Among Physicians". This is eye opening research and demonstrates areas where more work needs to be done. (Authors: Dr. Alnoor Ramji, Dr. Keyur Patel, Dr. Mark Swain, Dr. Giada Sebastiani)
Is it worth case finding NAFLD and NASH in our patients? Are we opening a can of worms? What are the implications of advanced liver disease? Why look for fatty liver disease, if all you can do is 'diet and exercise'? Dr. Alnoor Ramji, Hepatologist, and Michael Betel discuss these questions and more.his great video
Welcome to FLA on the road! Our first guest is Dr. Supriya Joshi, Hepatologist and we discuss fast food nutrition and the impact on liver health.
It is very clear that one specialist alone cannot offer all the medical care a NASH patient will need. It is time for a multidisciplinary, team approach. How will that work? Is it already happening? Watch this engaging discussion with Dr. Kenneth, Endocrinologist, Dr. Mark Swain, Hepatologist and Dr. Ming Jun, Primary Care Physician focused on hepatology.
This highly interactive discussion between Endocrinologist, Dr. Kenneth Cusi, Dr. Mark Swain, Hepatologist and Michael Betel exploring the topic of obesity, type-2 diabetes and fatty liver disease.
Roger Green, President of Hep Dynamics, has been forecasting the NASH Tsunami on his podcast and enlightened listeners from around the world. Watch as Roger and Michael Betel discuss the backstory and outlook for NAFLD and NASH in 2022.
Join Dr. Naim Alkhouri, Dr. Mark Swain and Michael Betel as they discuss all the great advances in NAFLD and NASH in 2021!
Dr. Manal Abdelmalek, Hepatologist from Duke University shares her insights in the NAFLD/NASH landscape from 2021, with Michael Betel.
Dr. Naim Alkhouri discusses NAFLD and NASH, risks and recommendations,
Dr. Nadege Gunn discusses the myths of clinical trials (part 1).
Dr. Nadege Gunn discusses the myths of clinical trials (part 2).
An encore fireside chat about NAFLD and NASH with Drs. Tracey Simon, Naim Alkhouri, and Mark Swain
Drs. Tracey Simon, Naim Alkhouri, and Mark Swain discuss the mortality impact of NAFLD.
The creator of the FIB-4 liver assessment tool, Dr. Richard Sterling shares the background story of how this very popular tool was created and why.
Dr. Naim Alkhouri discusses NAFLD and NASH incidence being much higher than estimates.
Dr. Mark Swain shares advice for liver patients during the Covid-19 pandemic.
Dr. Robert Gish and the Weight Loss Roadmap
Dr. Giada Sebastiani discusses the silent epidemic of NAFLD.
Dr. Giada Sebastiani discusses the best diet for NAFLD and NASH patients.
Dr. Supriya Joshi discusses the importance of eating well to prevent or address NAFLD and NASH. Avoidance of sugar is a critical focus area.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.